Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05342753 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese Subjects
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT05342753 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 22 participants.
The verdict
NCT05342753, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Open-label, phase IV, post-marketing study to evaluate aesthetic improvement in Chinese subjects after treatment with Restylane Kysse.
Interventions
- DEVICE Restylane Kysse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-06-13 |
| Est. Completion | 2024-11-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05342753
The ClinicalTrials.gov registry entry for NCT05342753 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Restylane Kysse is the first listed.
NCT05342753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05342753 about?
NCT05342753 is a clinical study titled "Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese Subjects". Open-label, phase IV, post-marketing study to evaluate aesthetic improvement in Chinese subjects after treatment with Restylane Kysse.
What is the current status of trial NCT05342753?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2022-06-13. Estimated completion is 2024-11-07.
What interventions are being tested in trial NCT05342753?
The interventions under investigation include: Restylane Kysse (DEVICE).
Who is sponsoring clinical trial NCT05342753?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.